Acg Wealth Veru Inc. Transaction History

Acg Wealth

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 03, 2021	SELL	$8.05 - $20.78 $1.11 Million - $2.87 Million	-137,900 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$2.58 - $3.36 $96,492 - $125,664	37,400 Added 37.21%	137,900 $361,000
Q2 2020 Oct 07, 2020	SELL	$3.01 - $4.02 $1,505 - $2,009	-500 Reduced 0.5%	100,500 $336,000
Q3 2019 Oct 30, 2019	SELL	$1.81 - $2.36 $1,810 - $2,360	-1,000 Reduced 0.98%	101,000 $218,000
Q4 2018 Jan 14, 2019	BUY	$1.21 - $1.54 $30,250 - $38,500	25,000 Added 32.47%	102,000 $143,000
Q2 2018 Jul 26, 2018	BUY	$1.64 - $2.29 $126,279 - $176,330	77,000 New	77,000 $156,000
Q1 2018 Apr 10, 2018	SELL	$1.19 - $2.17 $89,250 - $162,750	-75,000 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$0.98 - $2.27 $24,500 - $56,750	25,000 Added 50.0%	75,000 $86,000
Q3 2017 Nov 07, 2017	BUY	$1.2 - $2.84 $60,000 - $142,000	50,000	50,000 $132,000

115

58M

539K

367K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $61.7M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

Stay updated on Acg Wealth with notifications on news.